Baseline and early on-treatment HBsAg level to predict HBsAg loss in nucleotide analog suppressed and HBeAg cleared chronic hepatitis B patients by switching to peginterferon alfa-2a: exploratory results of NEW SWITCH study
Authors:
- P. HuPHP. Hu
- Q. XieQXQ. Xie
- X. ChenXCX. Chen
- X. DouXDX. Dou
- J. JiangJJJ. Jiang
- J. ShangJSJ. Shang
- W. ZhangWZW. Zhang
- G. GongGGG. Gong
- Y. SunYSY. Sun
- Y. LiuYLY. Liu
- G. LiuGLG. Liu
- D. MaoDMD. Mao
- 1 January 2017
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 66 (1) , S265